Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
B. Wiegmann, D. Jonigk, P. Braubach, K. Höffler, S. Bachmann, J. Weder, A. Ciubutaro, A. Haverich (Hannover, Germany). Miniaturization of the organ care system^® into rat lungs for the establishment of ex-vivo therapy. Eur Respir J 2014; 44: Suppl. 58, 2304

Member's Comments

No comment yet.

Related content which might interest you: Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Intact serotonin signaling is not required for the development of severe angioproliferative pulmonary hypertension in rats Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Impact of sepsis in respiratory mechanics of pulmonary arterial hypertension rat model. Preliminary results Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 An overview of thrombolytic treatment for pulmonary embolism: A single center experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Epoprostenol dosing by concomitant therapies in the PROSPECT registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Improving the safety of right heart catheterisation in sickle cell disease Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Incorporation into lipid nanoparticles extends the duration of activity of treprostinil in an acute hypoxia rat model of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Obligatory role of MEK/ERK/RSK90 in the mitogenic responses of human pulmonary artery smooth muscle cells Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Inflammasome ASC-knock out attenuates the development of pulmonary hypertension caused by chronic alveolar hypoxia Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Pulmonary hemodynamics and lung function in patients with COPD and DPLD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Treprostinil pharmacokinetics in rats are extended using inhaled prodrug formulations Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 The evolution of effort tolerance and body composition in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Lung capillary blood volume and membrane diffusion in PH Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014